James C. Blair PH.D.
Dr. Blair has been a partner of Domain Associates since the company’s founding in 1985. Present board memberships include Astute Medical, Cadence Pharmaceuticals, Cell Biosciences, Clovis Oncology, CoDa Therapeutics, Five Prime Therapeutics, GenVault, IntegenX, Meritage Pharma, NeuroPace, and Zogenix. Dr. Blair has more than 40 years experience with venture and emerging growth companies. In the course of his experience, he has been involved in the creation and successful development at the board level of more than 40 life sciences ventures, including Amgen, Aurora Biosciences, Amylin Pharmaceuticals, Applied Biosystems, Dura Pharmaceuticals, GeneOhm Sciences, Molecular Dynamics, Nuvasive, Pharmion and Volcano. A former managing director of Rothschild, Dr. Blair was directly involved at a senior level with Rothschild/New Court venture capital activities. He was also associated with F.S. Smithers and Co. and White, Weld and Co., two investment banking firms actively involved with new ventures and emerging growth companies. Dr. Blair was an engineering manager with RCA Corporation, during which time he received the David Sarnoff Fellowship. Dr. Blair currently serves on the board of directors of the Prostate Cancer Foundation and on the advisory boards of the Department of Molecular Biology at Princeton University, the Department of Biomedical Engineering at the University of Pennsylvania, the USC Stevens Institute for Innovation, and the Division of Chemistry and Chemical Engineering at the California Institute of Technology.